Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 88726901000001113 | Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 88727001000001112 | Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Is a | Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has active ingredient | Sodium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has active ingredient | Potassium bicarbonate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has manufactured dose form | Oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | VMP non-availability indicator | Re-introduced | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has specific active ingredient | Sodium alginate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has specific active ingredient | Potassium bicarbonate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has dispensed dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) 60 tablet | Has AMP | False | Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (J M McGill Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR